Loading...

iShares Genomics Immunology and Healthcare ETF

IDNAAMEX
Financial Services
Asset Management
$20.51
$0.06(0.29%)

iShares Genomics Immunology and Healthcare ETF IDNA Peers

See (IDNA) competitors and their performances in Stock Market.

Peer Comparison Table: Asset Management Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IDNA$20.51+0.29%103.1M16.34$1.26+1.29%
VFINX$572.69+0.77%1.5T26.90$21.24+1.23%
VOO$568.03+0.19%1.5T26.95$21.07+1.23%
VITSX$148.03+0.71%1.3T26.13$5.65+1.32%
VTSAX$148.01+0.71%1.3T26.13$5.65+1.23%
FXAIX$216.11+1.06%655.7BN/AN/AN/A
VTI$303.93+0.20%630.2B26.19$11.61+1.23%
IVV$620.90+0.56%595.3B26.71$23.24+1.29%
SPY$617.85+0.48%567.1B26.71$23.13+1.16%
VTSNX$148.37+0.69%506.9B16.50$8.97+2.83%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IDNA vs VFINX Comparison

IDNA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IDNA stands at 103.1M. In comparison, VFINX has a market cap of 1.5T. Regarding current trading prices, IDNA is priced at $20.51, while VFINX trades at $572.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IDNA currently has a P/E ratio of 16.34, whereas VFINX's P/E ratio is 26.90. In terms of profitability, IDNA's ROE is +0.00%, compared to VFINX's ROE of +0.00%. Regarding short-term risk, IDNA is more volatile compared to VFINX. This indicates potentially higher risk in terms of short-term price fluctuations for IDNA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;